Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib

JOURNAL OF CLINICAL ONCOLOGY

AMER SOC CLINICAL ONCOLOGY

1. NCI NIH HHS [1K12CA87723-01, 1R01CA114465-01, P20CA90578-02] Funding Source: Medline